SUTRO BIOPHARMA CEO William Newell's 2021 pay jumps 161% to $5.6M
SUTRO BIOPHARMA reports 2021 executive compensation
By ExecPay News
Published: April 22, 2022
SUTRO BIOPHARMA reported fiscal year 2021 executive compensation information on April 22, 2022.
In 2021, five executives at SUTRO BIOPHARMA received on average a compensation package of $3.6M, a 146% increase compared to previous year.
Average pay of disclosed executives at SUTRO BIOPHARMA
William J. Newell, Chief Executive Officer, received $5.6M in total, which increased by 161% compared to 2020. 53% of Newell's compensation, or $3M, was in option awards. Newell also received $394K in non-equity incentive plan, $625K in salary, $1.6M in stock awards, as well as $38K in other compensation.
Jane Chung, Chief Commercial Officer, received a compensation package of $4.3M. 48% of the compensation package, or $2M, was in option awards.
Trevor Hallam, Chief Scientific Officer, earned $3.4M in 2021, a 176% increase compared to previous year.
Arturo Molina, Chief Medical Officer, received $2.6M in 2021, which increases by 125% compared to 2020.
Edward Albini, Chief Financial Officer, earned $2.1M in 2021.
Related executives
You may also like
Source: SEC filing on April 22, 2022.